Search company, investor...
Vineti company logo


Founded Year



Series C - II | Alive

Total Raised


Last Raised

$33M | 3 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+50 points in the past 30 days

About Vineti

Vineti is a commercial, configurable cloud-based platform to expand patient access to life-saving cell and gene therapies. Vineti was co-founded by GE and the Mayo Clinic to solve the key challenges patients, medical providers, biopharmaceutical companies and regulators face in the delivery and commercialization of individualized therapies. Now a fully independent company, Vineti offers a digital platform of record to integrate logistics, manufacturing and clinical data for personalized therapies. The Vineti software solution aligns and orchestrates the cell and gene therapy process and improve product performance overall. The Vineti platform supports the full continuum of patient-specific therapies, including cancer vaccines and autologous and allogeneic therapies. The platform can also be harnessed for drug products requiring companion diagnostics or REMS programs.

Headquarters Location

633 Howard St.

San Francisco, California, 94105,

United States

(415) 704-8730

Vineti's Product Videos

Compete with Vineti?

Ensure that your company and products are accurately represented on our platform.

Vineti's Products & Differentiators

    Personalized Therapy Management (PTM) Enterprise

    PTM Enterprise™ drives the advanced therapy patient journey, from autologous and allogeneic cell and gene therapies to personalized cancer vaccines, from clinical trials through commercialization. Personalized therapeutics have the potential to transform lives. But as a promising product scales and approaches commercialization, advanced therapy innovators face significant obstacles in getting treatments to the patients who need them: Your enabling technology may lag behind your science Your existing software systems may not be integrated with each other, and they don’t scale Complex regulatory and compliance processes threaten to slow your project with document and data management challenges and potential regulatory delays Uneven ongoing data management keeps COGS very high

Research containing Vineti

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Vineti in 2 CB Insights research briefs, most recently on Jan 24, 2023.

Expert Collections containing Vineti

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vineti is included in 4 Expert Collections, including Digital Health 150.


Digital Health 150

300 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Digital Health

10,347 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Vineti Patents

Vineti has filed 6 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date


Related Topics




Clusters of differentiation, Immunology, Immune system, Configuration management, Cancer treatments


Application Date


Grant Date



Related Topics

Clusters of differentiation, Immunology, Immune system, Configuration management, Cancer treatments



Latest Vineti News

Manufacturing Execution System (MES) Providers in Healthcare Market Worth $24.16 Billion with CAGR of 22.58% to 2030 | InsightAce Study

May 16, 2023

Healthcare Market is worth US$ 4.77 Billion in 2022 and is predicted to reach US$ 24.16 Billion in 2030, with a promising CAGR of 22.58% during the forecast period of 2023 to 2030. The key market players are GE Digital, Andea, Critical Manufacturing, Dassault Systèmes, Rockwell Automation, Infor, Körber, LZ Lifescience Inc., Honeywell, Trunovate, NoMuda, HCL Technologies Limited, ORDINAL Software, Atachi Systems, ATS Global, MasterControl, Inc., NNIT, Aspen Technology Inc, Goodly-Innovations GmbH, ADVANCO SA, Enhanced Information Solution, POMS Corporation, Tulip, Siemens, GFOS, znt-Richter, Other Prominent Players. Free PDF Report Brochure @ Key Market Developments: • In Aug 2022, An agreement between Ernst & Young LLP (EY US) and GE Digital was recently announced with the goal of assisting enterprises in modernizing their industrial operations. Together, GE and EY US bring more than a century's worth of industry knowledge and a wealth of digital technologies to the collaboration. EY US is responsible for providing consultancy services. As a result of this agreement, manufacturers will have access to support from EY US teams that will enable them to adopt and integrate technologies developed by GE Digital to create more data-driven manufacturing operations. • In Oct 2021, Korber announced cooperation with Vineti to connect their market-leading Personalized Therapy Management (PTM) technology with its Werum, PAS-X MES software. As a result of the cooperation, biopharma customers will have access to an integrated PAS-X MES as well as supply chain and data management solutions, enabling them to provide patients in need with potentially life-saving cell and gene-based medicines. • In Sept 2021, Honeywell had expanded its digital automation capabilities in the life sciences through the acquisition of Performix, Inc. Honeywell's extensive array of automation solutions for the industry will soon include the MES software that Performix has developed. Users of the MES Platform from Performix have access to a modular collection of features designed to handle important components of the manufacturing process. Together, they speed up product expansion in order to give a global set of digital solutions that handle the rising complexity of production. • In Feb 2021, Atachi Systems committed to providing free MES software for one year to the first fifty small manufacturers in the fields of pharmaceuticals, medical devices, and diagnostics. To hasten the production of antiviral medications, diagnostic tools, and medical equipment, as well as bring these items to market in order to combat the Coronavirus. Some major key players in the Manufacturing Execution System (MES) Providers in Healthcare Market: Andea,

Vineti Frequently Asked Questions (FAQ)

  • When was Vineti founded?

    Vineti was founded in 2016.

  • Where is Vineti's headquarters?

    Vineti's headquarters is located at 633 Howard St., San Francisco.

  • What is Vineti's latest funding round?

    Vineti's latest funding round is Series C - II.

  • How much did Vineti raise?

    Vineti raised a total of $115.31M.

  • Who are the investors of Vineti?

    Investors of Vineti include Threshold Ventures, GE Ventures, Canaan Partners, Section 32, dRx Capital and 10 more.

  • Who are Vineti's competitors?

    Competitors of Vineti include TrakCel.

  • What products does Vineti offer?

    Vineti's products include Personalized Therapy Management (PTM) Enterprise and 1 more.

Compare Vineti to Competitors

TrakCel Logo

TrakCel's cell, gene, and immunotherapy management solution improves clinical study efficacy and accelerates global scale-up and scale-out by implementing communications technology to integrate the delivery path from needle-to-needle. The technology provides interactive instructions to professionals across the supply chain and gives stakeholders on-demand visibility of procedural results and chain-of-custody data for immediate trace-ability, validation, and compliance audits.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.